Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-132544
Filing Date
2024-12-30
Accepted
2024-12-30 17:08:17
Documents
4
Period of Report
2025-02-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2431486-2_def14a.htm DEF 14A 167950
2 GRAPHIC lg_transcodetheraptm-4c.jpg GRAPHIC 10109
3 GRAPHIC px_24transcodepxy01pg01-bw.jpg GRAPHIC 259076
4 GRAPHIC px_24transcodepxy01pg02-bw.jpg GRAPHIC 228152
  Complete submission text file 0001104659-24-132544.txt   794695
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40363 | Film No.: 241590515
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)